Pfizer needs to ‘fix what they have’, no M&A capacity, says BMO’s Evan Seigerman on activist stake

Evan David Seigerman, BMO Biotech Analyst, joins ‘Closing Bell Overtime’ to talk Pfizer shares climbing on activist firm Starboard taking a stake in the company.